Showing results (331-340 of 356) with videos related to
Sort By:
Pageof 36
Circulation|November 10, 2025
High-Dose vs. Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: The FLUNITY-HD Prespecified Pooled AnalysisNiklas Dyrby Johansen, Daniel Modin, Jacobo Pardo-Seco, et al.American Heart Journal|May 31, 2026
A Pragmatic Randomized Trial to Evaluate the Vaccine Effectiveness of Bivalent RSV prefusion F Vaccine for Preventing RSV Hospitalizations in Adults (DAN-RSV): Trial Design UpdateMats C Højbjerg Lassen, Sine H Christensen, Niklas D Johansen, et al.Lancet (London, England)|October 20, 2025
Effectiveness of high-dose influenza vaccine against hospitalisations in older adults (FLUNITY-HD): an individual-level pooled analysisNiklas Dyrby Johansen, Daniel Modin, Jacobo Pardo-Seco, et al.BMC Infectious Diseases|February 16, 2023
Serological response to vaccination in post-acute sequelae of COVIDSandy Joung, Brittany Weber, Min Wu, et al.Circulation|April 7, 2024
Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-AnalysisSiddharth M Patel, Yu Mi Kang, KyungAh Im, et al.Stroke|October 6, 2023
Effect of Time to Thrombolysis on Clinical Outcomes in Patients With Acute Ischemic Stroke Treated With Tenecteplase Compared to Alteplase: Analysis From the AcT Randomized Controlled TrialNishita Singh, Mohammed A Almekhlafi, Fouzi Bala, et al.European Heart Journal|March 26, 2026
Sex differences in cardiovascular-kidney-metabolic syndrome: the FINE-HEART pooled analysisMaria A Pabon, John W Ostrominski, Xiaowen Wang, et al.Circulation. Heart Failure|April 19, 2021
Global Differences in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF TrialJasper Tromp, Brian L Claggett, Jiankang Liu, et al.Journal of the American Heart Association|June 21, 2024
Aptamer Proteomics for Biomarker Discovery in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Proteomic SubstudyNatasha L Patel-Murray, Luqing Zhang, Brian L Claggett, et al.Circulation|December 5, 2024
Low Penetrance Sarcomere Variants Contribute to Additive Risk in Hypertrophic CardiomyopathyJoshua K Meisner, Aaron Renberg, Eric D Smith, et al.Pageof 36